AXSM - Axsome Therapeutics settles Sunosi patent litigation with Unichem Laboratories
2024-06-05 08:12:48 ET
More on Axsome Therapeutics
- Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments
- Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
- Axsome Therapeutics Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Axsome Therapeutics